European Equities Traded in the US as American Depositary Receipts Sharply Lower in Thursday Trading
European equities traded in the US as American depositary receipts were sharply lower late Thursday morning, falling 1.60% to 1,418.28 on the S&P Europe Select ADR Index. From continental Europe, the
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday.Shares of Tesla Inc (NASDAQ:TSLA) rose sharply during Thursday's session after CEO Elon Musk said the company's s
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
European equities traded in the US as American depositary receipts were moving sharply higher late Wednesday morning, rising 1.59% to 1,445.87 on the S&P Europe Select ADR Index. From continental Euro
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading
European equities traded in the US as American depositary receipts were trending sharply lower late Tuesday morning, falling 1.34% to 1,420.05 on the S&P Europe Select ADR Index. From continental Euro
Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
Tech firms were leading European equities traded in the US as American depositary receipts moderately higher late Thursday morning, rising 0.50% to 1,448.39 on the S&P Europe Select ADR Index. From co
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading
European equities traded in the US as American depositary receipts fell in Monday trading, declining 0.53% to 1,420.98 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower
European equities traded in the US as American depositary receipts rose Friday morning, gaining 0.61% to 1,418.20 on the S&P Europe Select ADR Index. The index is poised to end the week lower. From co
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading
European equities traded in the US as American depositary receipts started the shortened trading week lower late Tuesday morning, declining 0.29% to 1,420.49 on the S&P Europe Select ADR Index. From c
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
Tech stocks led European equities traded in the US as American depositary receipts modestly higher Thursday morning, rising 0.4% to 1,428.1 on the S&P Europe Select ADR Index. From continental Europe,
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
European equities traded in the US as American depositary receipts fell Wednesday morning, declining 0.48% to 1,423.09 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading
European equities traded in the US as American depositary receipts opened the week slightly higher Monday morning, rising 0.12% to 1,429.79 on the S&P Europe Select ADR Index. From continental Europe,
Express News | HC Wainwright & Co. Reiterates Buy on Verona Pharma, Maintains $32 Price Target
Verona Pharma Is Maintained at Buy by HC Wainwright & Co.
Verona Pharma Is Maintained at Buy by HC Wainwright & Co.
Verona Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 102.02% HC Wainwright & Co. $33 → $30 Maintains Buy 04/16/2024 142.42% Piper Sandler $31 → $36
Strategic Financing Secures Verona Pharma's Future Beyond 2026, Ensuring Buy Rating
Positive Outlook for Verona Pharma With Strong Financial Position and Anticipated Drug Approval
Express News | Verona Pharma PLC : H.c. Wainwright Cuts Target Price to $30 From $33
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
Verona Pharma Plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
No Data